GB0021927D0 - Use of pharmaceutical combination - Google Patents

Use of pharmaceutical combination

Info

Publication number
GB0021927D0
GB0021927D0 GBGB0021927.9A GB0021927A GB0021927D0 GB 0021927 D0 GB0021927 D0 GB 0021927D0 GB 0021927 A GB0021927 A GB 0021927A GB 0021927 D0 GB0021927 D0 GB 0021927D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical combination
pharmaceutical
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0021927.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0021927.9A priority Critical patent/GB0021927D0/en
Publication of GB0021927D0 publication Critical patent/GB0021927D0/en
Priority to PCT/GB2001/004001 priority patent/WO2002019995A2/en
Priority to AU2001284287A priority patent/AU2001284287A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GBGB0021927.9A 2000-09-07 2000-09-07 Use of pharmaceutical combination Ceased GB0021927D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0021927.9A GB0021927D0 (en) 2000-09-07 2000-09-07 Use of pharmaceutical combination
PCT/GB2001/004001 WO2002019995A2 (en) 2000-09-07 2001-09-06 Pharmaceutical combination containing salmeterol and fluticasone
AU2001284287A AU2001284287A1 (en) 2000-09-07 2001-09-06 Pharmaceutical combination containing salmeterol and fluticasone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021927.9A GB0021927D0 (en) 2000-09-07 2000-09-07 Use of pharmaceutical combination

Publications (1)

Publication Number Publication Date
GB0021927D0 true GB0021927D0 (en) 2000-10-25

Family

ID=9899002

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0021927.9A Ceased GB0021927D0 (en) 2000-09-07 2000-09-07 Use of pharmaceutical combination

Country Status (3)

Country Link
AU (1) AU2001284287A1 (en)
GB (1) GB0021927D0 (en)
WO (1) WO2002019995A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124523D0 (en) * 2001-10-12 2001-12-05 Glaxo Group Ltd Pharmaceutical combination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0416925A3 (en) * 1989-09-07 1991-09-25 Glaxo Group Limited Use of 4-hydroxy-alpha 1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol or its salts in the treatment of allergy and inflammation
EP0954318A1 (en) * 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
GB9622173D0 (en) * 1996-10-24 1996-12-18 Glaxo Group Ltd Particulate Products
GB9924992D0 (en) * 1999-10-21 1999-12-22 Glaxo Group Ltd Pharmaceutical aerosol formulations
EP1248597B1 (en) * 1999-12-24 2005-03-30 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate

Also Published As

Publication number Publication date
AU2001284287A1 (en) 2002-03-22
WO2002019995A3 (en) 2002-08-22
WO2002019995A2 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
EP1367060A4 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
EP1364957A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
EP1364958A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
GB0006133D0 (en) Novel pharmaceutical
GB0020691D0 (en) Pharmaceutical combination
GB0025473D0 (en) Pharmaceutical combinations
HK1057474A1 (en) Medicinal composition
GB0012291D0 (en) Pharmaceutical combination
AU7402201A (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
GB0018887D0 (en) Compound and their therapeutic use
GB0014006D0 (en) Novel pharmaceutical
GB0021927D0 (en) Use of pharmaceutical combination
GB0021487D0 (en) Pharmaceutical
GB0024517D0 (en) Use of medicaments
HK1053059A1 (en) New use of imidazotriazinon derivatives
GB0014005D0 (en) Novel pharmaceutical
GB0012293D0 (en) Pharmaceutical combination
GB0128138D0 (en) Pharmaceutical use
GB0028565D0 (en) Pharmaceutical use
GB0111745D0 (en) Sterilization of pharmaceuticals
GB0016426D0 (en) Pharmaceutical combination
GB0020767D0 (en) Pharmaceutical combination
GB0016427D0 (en) Pharmaceutical combination
GB0016428D0 (en) Pharmaceutical combination
GB0016429D0 (en) Pharmaceutical combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)